DrugInformations.org

A new study published in Endocrine Practice found that a substantial percentage of patients with nodules, or growths, in their adrenal glands were not being properly evaluated by physicians. Adrenal glands are located at the top of each kidney. They make hormones that are critical for survival such as adrenaline and cortisol that are best known for dealing with stress. The study, lead by Dr.

More: continued here

No Comments »

ORLANDO, FL (UroToday.com) - Dr. Matthew Smith of Harvard University addressed toxicities of hormonal therapy. Initiating ADT for men with CaP brings challenges. Many have indolent disease and co-morbid conditions and there is inadequate information about benefits. Initial use of DES was abandoned when the two-fold increase in thromboembolic events were noted. He said we must still assess present GnRH agonists use for any toxicities as well. For most men CaP is indolent.

More: continued here

No Comments »

The use of hormone replacement therapy (HRT) by senior Canadian women in five provinces has dropped from 14% to 5% since the publication of the 2002 Women’s Health Initiative (WHI) study, which found the health risks of using HRT outweighed the benefits.

More: continued here

No Comments »

During the course of her PhD studies, Randi Sorby demonstrated that ellipsoids, small filtering units for blood in the spleen, might be significant in the development of AA amyloidosis. AA amyloidosis is a potential complication of chronic inflammation or infection, for example, rheumatoid arthritis and tuberculosis, and is characterised by systematic deposition of protein fibrils in the tissues of organs such as the spleen and liver.

More: continued here

No Comments »

ORLANDO, FL (UroToday.com) - Dr. Kazuya Tanase and colleagues from Fukui, Japan demonstrated that estrogen deficiency may cause up-regulation of C-fiber afferent activity from the bladder that can result in bladder hypersensitivity.

More: continued here

No Comments »

Some British women are in denial when it comes to the menopause, according to results of a new survey released. They are also failing to recognise the discreet early symptoms leading to a possible delay in seeking essential advice and treatment.1 The research reveals that a staggering one in ten women are unaware that the menopause is a naturally occurring event affecting all women as they enter midlife.

More: continued here

No Comments »

In older men with low testosterone levels, testosterone replacement therapy improves their risk factors for cardiovascular disease and diabetes, according to two new studies. The results were presented at The Endocrine Society’s 90th Annual Meeting in San Francisco.Testosterone deficiency becomes more common with age, occurring in 18 percent of 70-year-olds, said a coauthor of both studies, Farid Saad, PhD, of Berlin-headquartered Bayer Schering Pharma.

More: continued here

No Comments »

Tercica, Inc. (NASDAQ: TRCA) announced the first results from the Increlex® Growth Forum Database (IGFD) Registry in two posters presented at the 90th annual meeting of the Endocrine Society in San Francisco. Increlex® (mecasermin (rDNA origin) injection) is currently approved in the United States for the treatment of severe Primary IGF-1 Deficiency.

More: continued here

No Comments »

Researchers have found potential new biomarkers for growth hormone, which they say could help the sports community in detecting growth hormone abuse. The results of the animal study were presented at The Endocrine Society’s 90th Annual Meeting in San Francisco.Many athletes are misusing recombinant human growth hormone, a drug intended for people who are growth hormone deficient, because of its supposed ability to decrease fat and increase muscle.

More: continued here

No Comments »

Men may not live as long if they have low testosterone, regardless of their age, according to a new study. The results were presented at The Endocrine Society’s 90th Annual Meeting in San Francisco.The new study, from Germany, adds to the scientific evidence linking deficiency of this sex hormone with increased death from all causes over time - so-called “all-cause mortality.

More: continued here

No Comments »